# 2ndOpinion Automation Report: Oncology case-brief generator

*Oncology case-brief generator workflow transforms a standard clinical document packet into a consistent, sourced, decision-ready case brief.*

**Execution Date:** 8/25/2026, 4:49:41 PM
**Status:** completed · **Steps Executed:** 12 · **Cloud Calls:** 12

---

## Execution Step Outputs

### Step 1: Pathology agent (step)

{
  "document_domain": "pathology",
  "summary": "",
  "facts": [
    {
      "field": "specimen_type",
      "value": "Partial mastectomy with sentinel lymph node biopsy",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Final pathology after partial mastectomy and sentinel node biopsy.",
      "extraction_confidence": "high"
    },
    {
      "field": "tumor_size",
      "value": "1.4 cm",
      "qualifier": "greatest dimension",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Residual invasive tumor 1.4 cm greatest dimension.",
      "extraction_confidence": "high"
    },
    {
      "field": "histologic_grade",
      "value": "Nottingham grade 2 of 3",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Histologic grade: Nottingham grade 2 of 3.",
      "extraction_confidence": "high"
    },
    {
      "field": "in_situ_component",
      "value": "Focal intermediate-grade ductal carcinoma in situ (DCIS)",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "In situ component: Focal intermediate-grade DCIS.",
      "extraction_confidence": "high"
    },
    {
      "field": "margin_status",
      "value": "All submitted margins negative for invasive carcinoma and DCIS; closest invasive margin 6 mm",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Margins: all margins negative; closest invasive margin 6 mm.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymphovascular_invasion",
      "value": "Not identified",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Lymphovascular invasion not identified.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymph_nodes_examined",
      "value": "3",
      "qualifier": "nodes examined",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Lymph nodes: 0 of 3 nodes positive; treatment-related fibrosis present in the clipped node.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymph_node_metastasis",
      "value": "0 positive",
      "qualifier": "in sentinel node(s)",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "0 of 3 lymph nodes positive for carcinoma.",
      "extraction_confidence": "high"
    },
    {
      "field": "treatment_related_fibrosis_in_node",
      "value": "present in clipped node",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Treatment-related fibrosis present in the clipped node.",
      "extraction_confidence": "high"
    },
    {
      "field": "estrogen_receptor",
      "value": "Positive",
      "qualifier": "percentage",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "ER: Positive - 90% strong nuclear staining.",
      "extraction_confidence": "high"
    },
    {
      "field": "progesterone_receptor",
      "value": "Negative",
      "qualifier": "percentage",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "PR: Negative - <1% nuclear staining.",
      "extraction_confidence": "high"
    },
    {
      "field": "HER2",
      "value": "Negative",
      "qualifier": "IHC score 1+",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "HER2: Negative - IHC score 1+.",
      "extraction_confidence": "high"
    },
    {
      "field": "ki_67",
      "value": "15%",
      "qualifier": "manual estimate",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Ki-67 15% Manual estimate.",
      "extraction_confidence": "high"
    },
    {
      "field": "pathologic_stage",
      "value": "ypT1c ypN0(sn)",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Pathologic stage: ypT1c ypN0(sn).",
      "extraction_confidence": "high"
    },
    {
      "field": "notes",
      "value": "Findings consistent with residual treated breast carcinoma; clipped axillary node shows treatment effect without residual metastatic carcinoma.",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Findings are consistent with residual treated breast carcinoma; clipped axillary node shows treatment effect without residual metastatic carcinoma.",
      "extraction_confidence": "high"
    }
  ],
  "events": [
    {
      "event_type": "surgical_pathology_final_report",
      "description": "Final pathology report issued for partial mastectomy and sentinel lymph node biopsy.",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "associated_facts": [
        "tumor_size: 1.4 cm",
        "histologic_grade: Nottingham grade 2 of 3",
        "in_situ_component: focal intermediate-grade DCIS",
        "margin_status: margins negative; closest margin 6 mm",
        "lymph_nodes_examined: 3",
        "lymph_node_metastasis: 0",
        "ER: 90% positive",
        "PR: <1% staining",
        "HER2: 1+",
        "Ki-67: 15%",
        "pathologic_stage: ypT1c ypN0(sn)"
      ],
      "extraction_confidence": "high"
    },
    {
      "event_type": "biomarker_results_reported",
      "description": "Predictive biomarkers reported: ER, PR, HER2, Ki-67.",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "associated_facts": [
        "ER: Positive 90%",
        "PR: Negative <1%",
        "HER2: Negative 1+",
        "Ki-67: 15%"
      ],
      "extraction_confidence": "high"
    }
  ],
  "uncertainties": [
    {
      "field": "specimen collection date",
      "value": null,
      "qualifier": null,
      "notes": "No specimen collection date provided in the document."
    }
  ],
  "missing_information": [
    "Specimen collection date not provided.",
    "Exact margins distance beyond closest invasive margin not specified beyond 6 mm."
  ]
}

---

### Step 2: Imaging agent (step)

{
  "document_domain": "imaging",
  "summary": "Partial imaging response to neoadjuvant therapy with residual 1.7 cm enhancement at the left breast malignancy; interval normalization of the previously biopsy-proven metastatic left axillary node; no new suspicious findings.",
  "facts": [
    {
      "field": "left_breast_residual_lesion",
      "value": "1.7 cm enhancement at known left-breast malignancy",
      "qualifier": "residual",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Impression: Partial imaging response ... residual 1.7 cm enhancement at the known left-breast malignancy.",
      "confidence": "high"
    },
    {
      "field": "left_axillary_node",
      "value": "interval normalization; previously metastatic left axillary node",
      "qualifier": "normalization",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Interval normalization of the previously biopsy-proven metastatic left axillary node.",
      "confidence": "high"
    },
    {
      "field": "left_axillary_node_biopsy_clip",
      "value": "present",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Biopsy clip is present.",
      "confidence": "high"
    },
    {
      "field": "right_breast",
      "value": "no suspicious enhancement",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Right breast: No suspicious enhancement.",
      "confidence": "high"
    },
    {
      "field": "skin_chest_wall",
      "value": "no skin thickening or chest-wall invasion",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Skin / chest wall: No skin thickening or chest-wall invasion.",
      "confidence": "high"
    },
    {
      "field": "comparison_reference",
      "value": "Breast MRI 2026-04-23",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "comparison",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Comparison: Breast MRI 2026-04-23.",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "event_date": "2026-07-29",
      "date_precision": "day",
      "event_type": "imaging",
      "summary": "Breast MRI performed for treatment response; partial response with residual left-breast enhancement and normalization of left axillary node.",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 3: clinical notes agent (step)

{
  "document_domain": "clinical",
  "summary": "Post-neoadjuvant therapy for left breast cancer with partial radiographic response. Planned breast-conserving surgery (left partial mastectomy with sentinel node biopsy and removal of clipped node). Postoperative systemic and radiation plans to be finalized after pathology review.",
  "facts": [
    {
      "field": "initial_diagnosis",
      "value": "Left-breast invasive ductal carcinoma",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Primary diagnosis: Left-breast invasive ductal carcinoma; diagnosed in April 2026.",
      "confidence": "high"
    },
    {
      "field": "anatomical_site",
      "value": "Left breast",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Left-breast cancer noted; imaging and plan pertain to left breast.",
      "confidence": "high"
    },
    {
      "field": "stage_group",
      "value": "AJCC 8th edition stage IIB (cT2 cN1 cM0)",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Clinical stage provided as IIB (cT2 cN1 cM0).",
      "confidence": "high"
    },
    {
      "field": "biology",
      "value": "ER positive / PR negative / HER2 negative",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Biology noted as ER+/PR-, HER2-.",
      "confidence": "high"
    },
    {
      "field": "treatment_history",
      "value": "Neoadjuvant dose-dense doxorubicin/cyclophosphamide (ddAC) followed by paclitaxel",
      "qualifier": "historical",
      "event_date": "2026-04 to 2026-07",
      "date_precision": "range",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Completed neoadjuvant ddAC followed by paclitaxel; final paclitaxel dose administered 2026-07-20.",
      "confidence": "high"
    },
    {
      "field": "treatment_completion",
      "value": "Final paclitaxel dose administered",
      "qualifier": "completed",
      "event_date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Final paclitaxel dose given on 2026-07-20.",
      "confidence": "high"
    },
    {
      "field": "treatment_tolerability",
      "value": "Completed without dose-limiting toxicity",
      "qualifier": "historical",
      "event_date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Treatment completed without dose-limiting toxicity.",
      "confidence": "high"
    },
    {
      "field": "current_disease_state",
      "value": "Partial radiographic response to neoadjuvant therapy; residual enhancement at primary; no new suspicious lesions; axillary node not morphologically enlarged",
      "qualifier": "current",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Post-treatment MRI shows partial response; clipped node not enlarged.",
      "confidence": "high"
    },
    {
      "field": "current_symptoms",
      "value": "Mild residual fatigue; no active infection",
      "qualifier": "current",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Clinically well with mild fatigue and no active infection.",
      "confidence": "high"
    },
    {
      "field": "planned_surgery",
      "value": "Left partial mastectomy with image-guided localization and sentinel lymph-node biopsy with targeted removal of the previously clipped axillary node",
      "qualifier": "planned",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Plan to proceed with breast-conserving surgery including targeted lymph node removal.",
      "confidence": "high"
    },
    {
      "field": "postoperative_plans",
      "value": "Postoperative systemic therapy and radiation therapy recommendations to be finalized after pathology review",
      "qualifier": "planned",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Recommendations to be finalized after surgical pathology.",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "type": "treatment_initiation",
      "description": "Initiation of neoadjuvant chemotherapy (ddAC followed by paclitaxel)",
      "date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "treatment_completion",
      "description": "Completion of neoadjuvant chemotherapy (final paclitaxel dose on 2026-07-20)",
      "date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "response_assessment",
      "description": "Post-treatment MRI: partial radiographic response with residual enhancement at primary; no new lesions; axillary node no longer enlarged",
      "date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "surgical_plan",
      "description": "Breast-conserving surgery planned: left partial mastectomy with localization and sentinel node biopsy including removal of clipped node",
      "date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    }
  ],
  "uncertainties": [
    {
      "note": "Exact date of initial diagnosis in April 2026 not specified (day not given).",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "medium"
    },
    {
      "note": "Exact start date of neoadjuvant chemotherapy not stated; only end date of last cycle (2026-07-20) available.",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "medium"
    }
  ],
  "missing_information": [
    {
      "field": "exact_start_date_neoadjuvant_chemo",
      "reason": "Not provided in document",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "low"
    },
    {
      "field": "planned_radiation_timing",
      "reason": "TBD after pathology; no exact date given",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "field": "planned_systemic_postoperative_therapy",
      "reason": "Recommendations to be finalized after pathology review; no specifics yet",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    }
  ]
}

---

### Step 4: surgery agent (step)

{
  "document_domain": "surgery",
  "summary": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node performed for left breast invasive carcinoma after neoadjuvant therapy. Included removal of localization marker/clip within specimen; three sentinel/targeted axillary nodes excised (including clipped node); margins addressed with additional cavity margins. Estimated blood loss 20 mL. No intraoperative complications.",
  "facts": [
    {
      "fact_type": "operation_date",
      "value": "2026-08-07",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "procedure_name",
      "value": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "surgical_specialty",
      "value": "Surgical oncology / breast surgery",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "indication",
      "value": "Left-breast invasive carcinoma after neoadjuvant systemic therapy",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "anatomical_site",
      "value": "Left breast, upper outer quadrant",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "laterality",
      "value": "Left",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "operative_approach",
      "value": "Curvilinear incision; image-guided localization with marker/clip; separate axillary incision for sentinel lymphatic mapping",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "completed_procedures",
      "value": [
        "Left partial mastectomy",
        "Sentinel lymph-node biopsy",
        "Targeted excision of clipped axillary node"
      ],
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "tumor_or_clips_in_specimen",
      "value": "Localization marker and biopsy clip contained within the breast specimen",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "axillary_nodes_removed",
      "value": "Three sentinel/targeted axillary nodes removed, including the previously clipped node",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "gross_findings",
      "value": "No grossly abnormal additional axillary nodes identified",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "margins_and_dissection",
      "value": "Additional cavity margins obtained (superior, inferior, medial, lateral, anterior, posterior)",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "estimated_blood_loss",
      "value": "20 mL",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "specimens_submitted",
      "value": [
        "Left partial mastectomy specimen",
        "Additional margins: superior, inferior, medial, lateral, anterior, posterior",
        "Three left axillary nodes"
      ],
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "postoperative_status",
      "value": "Hemostasis achieved; patient transferred to recovery in stable condition",
      "source": "operative_report.pdf"
    }
  ],
  "events": [
    {
      "event_date": "2026-08-07",
      "date_precision": "day",
      "event_type": "surgery",
      "summary": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node performed; localization marker/clip within specimen; three axillary nodes removed including clipped node; margins addressed with additional cavity margins; estimated blood loss 20 mL; no intraoperative complications.",
      "source_file": "operative_report.pdf",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 5: Verify pathology  (step)

{
  "document_domain": "pathology",
  "summary": "",
  "facts": [
    {
      "field": "specimen_type",
      "value": "Partial mastectomy with sentinel lymph node biopsy",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Final pathology after partial mastectomy and sentinel node biopsy.",
      "extraction_confidence": "high"
    },
    {
      "field": "tumor_size",
      "value": "1.4 cm",
      "qualifier": "greatest dimension",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Residual invasive tumor 1.4 cm greatest dimension.",
      "extraction_confidence": "high"
    },
    {
      "field": "histologic_grade",
      "value": "Nottingham grade 2 of 3",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Histologic grade: Nottingham grade 2 of 3.",
      "extraction_confidence": "high"
    },
    {
      "field": "in_situ_component",
      "value": "Focal intermediate-grade ductal carcinoma in situ (DCIS)",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "In situ component: Focal intermediate-grade DCIS.",
      "extraction_confidence": "high"
    },
    {
      "field": "margin_status",
      "value": "All submitted margins negative for invasive carcinoma and DCIS; closest invasive margin 6 mm",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Margins: all margins negative; closest invasive margin 6 mm.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymphovascular_invasion",
      "value": "Not identified",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Lymphovascular invasion not identified.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymph_nodes_examined",
      "value": "3",
      "qualifier": "nodes examined",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Lymph nodes: 0 of 3 nodes positive; treatment-related fibrosis present in the clipped node.",
      "extraction_confidence": "high"
    },
    {
      "field": "lymph_node_metastasis",
      "value": "0 positive",
      "qualifier": "in sentinel node(s)",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "0 of 3 lymph nodes positive for carcinoma.",
      "extraction_confidence": "high"
    },
    {
      "field": "treatment_related_fibrosis_in_node",
      "value": "present in clipped node",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Treatment-related fibrosis present in the clipped node.",
      "extraction_confidence": "high"
    },
    {
      "field": "estrogen_receptor",
      "value": "Positive",
      "qualifier": "percentage",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "ER: Positive - 90% strong nuclear staining.",
      "extraction_confidence": "high"
    },
    {
      "field": "progesterone_receptor",
      "value": "Negative",
      "qualifier": "percentage",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "PR: Negative - <1% nuclear staining.",
      "extraction_confidence": "high"
    },
    {
      "field": "HER2",
      "value": "Negative",
      "qualifier": "IHC score 1+",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "HER2: Negative - IHC score 1+.",
      "extraction_confidence": "high"
    },
    {
      "field": "ki_67",
      "value": "15%",
      "qualifier": "manual estimate",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Ki-67 15% Manual estimate.",
      "extraction_confidence": "high"
    },
    {
      "field": "pathologic_stage",
      "value": "ypT1c ypN0(sn)",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Pathologic stage: ypT1c ypN0(sn).",
      "extraction_confidence": "high"
    },
    {
      "field": "notes",
      "value": "Findings consistent with residual treated breast carcinoma; clipped axillary node shows treatment effect without residual metastatic carcinoma.",
      "qualifier": null,
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "short_evidence": "Findings are consistent with residual treated breast carcinoma; clipped axillary node shows treatment effect without residual metastatic carcinoma.",
      "extraction_confidence": "high"
    }
  ],
  "events": [
    {
      "event_type": "surgical_pathology_final_report",
      "description": "Final pathology report issued for partial mastectomy and sentinel lymph node biopsy.",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "associated_facts": [
        "tumor_size: 1.4 cm",
        "histologic_grade: Nottingham grade 2 of 3",
        "in_situ_component: focal intermediate-grade DCIS",
        "margin_status: margins negative; closest margin 6 mm",
        "lymph_nodes_examined: 3",
        "lymph_node_metastasis: 0",
        "ER: 90% positive",
        "PR: <1% staining",
        "HER2: 1+",
        "Ki-67: 15%",
        "pathologic_stage: ypT1c ypN0(sn)"
      ],
      "extraction_confidence": "high"
    },
    {
      "event_type": "biomarker_results_reported",
      "description": "Predictive biomarkers reported: ER, PR, HER2, Ki-67.",
      "clinical_event_date": "2026-08-12",
      "date_type": "report date",
      "date_precision": "exact",
      "source_filename": "provided_document",
      "page": "N/A",
      "associated_facts": [
        "ER: Positive 90%",
        "PR: Negative <1%",
        "HER2: Negative 1+",
        "Ki-67: 15%"
      ],
      "extraction_confidence": "high"
    }
  ],
  "uncertainties": [
    {
      "field": "specimen collection date",
      "value": null,
      "qualifier": null,
      "notes": "No specimen collection date provided in the document."
    }
  ],
  "missing_information": [
    "Specimen collection date not provided.",
    "Exact margins distance beyond closest invasive margin not specified beyond 6 mm."
  ]
}

---

### Step 6: Verify imaging (step)

{
  "document_domain": "imaging",
  "summary": "Partial imaging response to neoadjuvant therapy with residual 1.7 cm enhancement at the left breast malignancy; interval normalization of the previously biopsy-proven metastatic left axillary node; no new suspicious findings.",
  "facts": [
    {
      "field": "left_breast_residual_lesion",
      "value": "1.7 cm enhancement at known left-breast malignancy",
      "qualifier": "residual",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Impression: Partial imaging response ... residual 1.7 cm enhancement at the known left-breast malignancy.",
      "confidence": "high"
    },
    {
      "field": "left_axillary_node",
      "value": "interval normalization; previously metastatic left axillary node",
      "qualifier": "normalization",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Interval normalization of the previously biopsy-proven metastatic left axillary node.",
      "confidence": "high"
    },
    {
      "field": "left_axillary_node_biopsy_clip",
      "value": "present",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Biopsy clip is present.",
      "confidence": "high"
    },
    {
      "field": "right_breast",
      "value": "no suspicious enhancement",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Right breast: No suspicious enhancement.",
      "confidence": "high"
    },
    {
      "field": "skin_chest_wall",
      "value": "no skin thickening or chest-wall invasion",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "visit",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Skin / chest wall: No skin thickening or chest-wall invasion.",
      "confidence": "high"
    },
    {
      "field": "comparison_reference",
      "value": "Breast MRI 2026-04-23",
      "qualifier": "",
      "examination_date": "2026-07-29",
      "date_type": "comparison",
      "date_precision": "day",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1,
      "short_supporting_evidence": "Comparison: Breast MRI 2026-04-23.",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "event_date": "2026-07-29",
      "date_precision": "day",
      "event_type": "imaging",
      "summary": "Breast MRI performed for treatment response; partial response with residual left-breast enhancement and normalization of left axillary node.",
      "source_file": "breast_mri_treatment_response_2026-07-29",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 7: clinical note verification (step)

{
  "document_domain": "clinical",
  "summary": "Post-neoadjuvant therapy for left breast cancer with partial radiographic response. Planned breast-conserving surgery (left partial mastectomy with sentinel node biopsy and removal of clipped node). Postoperative systemic and radiation plans to be finalized after pathology review.",
  "facts": [
    {
      "field": "initial_diagnosis",
      "value": "Left-breast invasive ductal carcinoma",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Primary diagnosis: Left-breast invasive ductal carcinoma; diagnosed in April 2026.",
      "confidence": "high"
    },
    {
      "field": "anatomical_site",
      "value": "Left breast",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Left-breast cancer noted; imaging and plan pertain to left breast.",
      "confidence": "high"
    },
    {
      "field": "stage_group",
      "value": "AJCC 8th edition stage IIB (cT2 cN1 cM0)",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Clinical stage provided as IIB (cT2 cN1 cM0).",
      "confidence": "high"
    },
    {
      "field": "biology",
      "value": "ER positive / PR negative / HER2 negative",
      "qualifier": "historical",
      "event_date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Biology noted as ER+/PR-, HER2-.",
      "confidence": "high"
    },
    {
      "field": "treatment_history",
      "value": "Neoadjuvant dose-dense doxorubicin/cyclophosphamide (ddAC) followed by paclitaxel",
      "qualifier": "historical",
      "event_date": "2026-04 to 2026-07",
      "date_precision": "range",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Completed neoadjuvant ddAC followed by paclitaxel; final paclitaxel dose administered 2026-07-20.",
      "confidence": "high"
    },
    {
      "field": "treatment_completion",
      "value": "Final paclitaxel dose administered",
      "qualifier": "completed",
      "event_date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Final paclitaxel dose given on 2026-07-20.",
      "confidence": "high"
    },
    {
      "field": "treatment_tolerability",
      "value": "Completed without dose-limiting toxicity",
      "qualifier": "historical",
      "event_date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Treatment completed without dose-limiting toxicity.",
      "confidence": "high"
    },
    {
      "field": "current_disease_state",
      "value": "Partial radiographic response to neoadjuvant therapy; residual enhancement at primary; no new suspicious lesions; axillary node not morphologically enlarged",
      "qualifier": "current",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Post-treatment MRI shows partial response; clipped node not enlarged.",
      "confidence": "high"
    },
    {
      "field": "current_symptoms",
      "value": "Mild residual fatigue; no active infection",
      "qualifier": "current",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Clinically well with mild fatigue and no active infection.",
      "confidence": "high"
    },
    {
      "field": "planned_surgery",
      "value": "Left partial mastectomy with image-guided localization and sentinel lymph-node biopsy with targeted removal of the previously clipped axillary node",
      "qualifier": "planned",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Plan to proceed with breast-conserving surgery including targeted lymph node removal.",
      "confidence": "high"
    },
    {
      "field": "postoperative_plans",
      "value": "Postoperative systemic therapy and radiation therapy recommendations to be finalized after pathology review",
      "qualifier": "planned",
      "event_date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "short_evidence": "Recommendations to be finalized after surgical pathology.",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "type": "treatment_initiation",
      "description": "Initiation of neoadjuvant chemotherapy (ddAC followed by paclitaxel)",
      "date": "2026-04",
      "date_precision": "month",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "treatment_completion",
      "description": "Completion of neoadjuvant chemotherapy (final paclitaxel dose on 2026-07-20)",
      "date": "2026-07-20",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "response_assessment",
      "description": "Post-treatment MRI: partial radiographic response with residual enhancement at primary; no new lesions; axillary node no longer enlarged",
      "date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "type": "surgical_plan",
      "description": "Breast-conserving surgery planned: left partial mastectomy with localization and sentinel node biopsy including removal of clipped node",
      "date": "2026-08-03",
      "date_precision": "date",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    }
  ],
  "uncertainties": [
    {
      "note": "Exact date of initial diagnosis in April 2026 not specified (day not given).",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "medium"
    },
    {
      "note": "Exact start date of neoadjuvant chemotherapy not stated; only end date of last cycle (2026-07-20) available.",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "medium"
    }
  ],
  "missing_information": [
    {
      "field": "exact_start_date_neoadjuvant_chemo",
      "reason": "Not provided in document",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "low"
    },
    {
      "field": "planned_radiation_timing",
      "reason": "TBD after pathology; no exact date given",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    },
    {
      "field": "planned_systemic_postoperative_therapy",
      "reason": "Recommendations to be finalized after pathology review; no specifics yet",
      "source_filename": "Medical Oncology Follow-up / preoperative handoff",
      "page": "1",
      "confidence": "high"
    }
  ]
}

---

### Step 8: surgery validation (step)

{
  "document_domain": "surgery",
  "summary": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node performed for left breast invasive carcinoma after neoadjuvant therapy. Included removal of localization marker/clip within specimen; three sentinel/targeted axillary nodes excised (including clipped node); margins addressed with additional cavity margins. Estimated blood loss 20 mL. No intraoperative complications.",
  "facts": [
    {
      "fact_type": "operation_date",
      "value": "2026-08-07",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "procedure_name",
      "value": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "surgical_specialty",
      "value": "Surgical oncology / breast surgery",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "indication",
      "value": "Left-breast invasive carcinoma after neoadjuvant systemic therapy",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "anatomical_site",
      "value": "Left breast, upper outer quadrant",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "laterality",
      "value": "Left",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "operative_approach",
      "value": "Curvilinear incision; image-guided localization with marker/clip; separate axillary incision for sentinel lymphatic mapping",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "completed_procedures",
      "value": [
        "Left partial mastectomy",
        "Sentinel lymph-node biopsy",
        "Targeted excision of clipped axillary node"
      ],
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "tumor_or_clips_in_specimen",
      "value": "Localization marker and biopsy clip contained within the breast specimen",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "axillary_nodes_removed",
      "value": "Three sentinel/targeted axillary nodes removed, including the previously clipped node",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "gross_findings",
      "value": "No grossly abnormal additional axillary nodes identified",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "margins_and_dissection",
      "value": "Additional cavity margins obtained (superior, inferior, medial, lateral, anterior, posterior)",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "estimated_blood_loss",
      "value": "20 mL",
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "specimens_submitted",
      "value": [
        "Left partial mastectomy specimen",
        "Additional margins: superior, inferior, medial, lateral, anterior, posterior",
        "Three left axillary nodes"
      ],
      "source": "operative_report.pdf"
    },
    {
      "fact_type": "postoperative_status",
      "value": "Hemostasis achieved; patient transferred to recovery in stable condition",
      "source": "operative_report.pdf"
    }
  ],
  "events": [
    {
      "event_date": "2026-08-07",
      "date_precision": "day",
      "event_type": "surgery",
      "summary": "Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node performed; localization marker/clip within specimen; three axillary nodes removed including clipped node; margins addressed with additional cavity margins; estimated blood loss 20 mL; no intraoperative complications.",
      "source_file": "operative_report.pdf",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 9: Lab results agent (step)

{
  "document_domain": "laboratory",
  "summary": "Preoperative CBC and CMP results.",
  "facts": [
    {
      "field": "hemoglobin",
      "value": 12.1,
      "qualifier": {
        "unit": "g/dL",
        "reference_range": "12.0 - 15.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Hemoglobin 12.1 12.0 - 15.5 g/dL",
      "confidence": "high"
    },
    {
      "field": "blood_cells",
      "value": 5.8,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "4.0 - 10.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "blood cells 5.8 4.0 - 10.5 10^9/L",
      "confidence": "high"
    },
    {
      "field": "absolute_neutrophil_count",
      "value": 3.4,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "1.5 - 7.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Absolute neutrophil count 3.4 1.5 - 7.5 10^9/L",
      "confidence": "high"
    },
    {
      "field": "platelets",
      "value": 231,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "150 - 400",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Platelets 231 150 - 400 10^9/L",
      "confidence": "high"
    },
    {
      "field": "creatinine",
      "value": 0.79,
      "qualifier": {
        "unit": "mg/dL",
        "reference_range": "0.50 - 1.10",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Creatinine 0.79 0.50 - 1.10 mg/dL",
      "confidence": "high"
    },
    {
      "field": "ast",
      "value": 22,
      "qualifier": {
        "unit": "U/L",
        "reference_range": "10 - 35",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "22 10 - 35 U/L",
      "confidence": "high"
    },
    {
      "field": "alt",
      "value": 19,
      "qualifier": {
        "unit": "U/L",
        "reference_range": "6 - 29",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "19 6 - 29 U/L",
      "confidence": "high"
    },
    {
      "field": "bilirubin_total",
      "value": 0.5,
      "qualifier": {
        "unit": "mg/dL",
        "reference_range": "0.2 - 1.2",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Total bilirubin 0.5 0.2 - 1.2 mg/dL",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "event_date": "2026-08-05",
      "event_type": "laboratory",
      "summary": "Preoperative CBC and CMP results.",
      "source_file": "lab_results.pdf",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 10: lab result validation (step)

{
  "document_domain": "laboratory",
  "summary": "Preoperative CBC and CMP results.",
  "facts": [
    {
      "field": "hemoglobin",
      "value": 12.1,
      "qualifier": {
        "unit": "g/dL",
        "reference_range": "12.0 - 15.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Hemoglobin 12.1 12.0 - 15.5 g/dL",
      "confidence": "high"
    },
    {
      "field": "blood_cells",
      "value": 5.8,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "4.0 - 10.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "blood cells 5.8 4.0 - 10.5 10^9/L",
      "confidence": "high"
    },
    {
      "field": "absolute_neutrophil_count",
      "value": 3.4,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "1.5 - 7.5",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Absolute neutrophil count 3.4 1.5 - 7.5 10^9/L",
      "confidence": "high"
    },
    {
      "field": "platelets",
      "value": 231,
      "qualifier": {
        "unit": "10^9/L",
        "reference_range": "150 - 400",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Platelets 231 150 - 400 10^9/L",
      "confidence": "high"
    },
    {
      "field": "creatinine",
      "value": 0.79,
      "qualifier": {
        "unit": "mg/dL",
        "reference_range": "0.50 - 1.10",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Creatinine 0.79 0.50 - 1.10 mg/dL",
      "confidence": "high"
    },
    {
      "field": "ast",
      "value": 22,
      "qualifier": {
        "unit": "U/L",
        "reference_range": "10 - 35",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "22 10 - 35 U/L",
      "confidence": "high"
    },
    {
      "field": "alt",
      "value": 19,
      "qualifier": {
        "unit": "U/L",
        "reference_range": "6 - 29",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "19 6 - 29 U/L",
      "confidence": "high"
    },
    {
      "field": "bilirubin_total",
      "value": 0.5,
      "qualifier": {
        "unit": "mg/dL",
        "reference_range": "0.2 - 1.2",
        "abnormal_flag": null
      },
      "event_date": "2026-08-05",
      "date_type": "specimen_collection",
      "date_precision": "day",
      "source_file": "lab_results.pdf",
      "page": 1,
      "evidence": "Total bilirubin 0.5 0.2 - 1.2 mg/dL",
      "confidence": "high"
    }
  ],
  "events": [
    {
      "event_date": "2026-08-05",
      "event_type": "laboratory",
      "summary": "Preoperative CBC and CMP results.",
      "source_file": "lab_results.pdf",
      "page": 1
    }
  ],
  "uncertainties": [],
  "missing_information": []
}

---

### Step 11: synthesis agent (step)

# Clinical Case Brief

## One-line summary
Post-neoadjuvant therapy left breast invasive ductal carcinoma with partial radiographic response; pathology shows residual treated tumor with negative margins and ypT1c ypN0(sn) status; axillary node metastasis not identified.

## Current Clinical Status
- Diagnosis: Left breast invasive ductal carcinoma.
- Stage/status: Pathologic stage ypT1c ypN0(sn) after partial mastectomy with sentinel node biopsy; margins negative (closest invasive margin 6 mm); residual in situ DCIS present; treatment-related fibrosis in clipped node; ER 90% positive, PR <1% (negative), HER2 1+ (negative); Ki-67 15%.
- Performance status: Not explicitly stated; clinically well with mild fatigue post-neoadjuvant therapy.
- Current treatment: Undergoing planned postoperative management; specifics of systemic therapy and radiation to be finalized after pathology review.

## Diagnosis & Pathology
- Specimen: Partial mastectomy with sentinel lymph node biopsy; clipped axillary node included.
- Tumor size: 1.4 cm (greatest dimension) residual invasive tumor.
- Histology: Nottingham grade 2 of 3 invasive carcinoma; focal intermediate-grade DCIS.
- Margins: All submitted margins negative for invasive carcinoma and DCIS; closest invasive margin 6 mm.
- Lymph nodes: 3 nodes examined; 0 positive for carcinoma; treatment-related fibrosis in the clipped node.
- Lymphovascular invasion: Not identified.
- Biomarkers: ER positive (90% strong nuclear staining); PR negative (<1%); HER2 negative (IHC 1+); Ki-67 15%.
- Pathologic stage: ypT1c ypN0(sn).

## Biomarkers / Molecular Findings
- Estrogen receptor: Positive (90%)
- Progesterone receptor: Negative (<1%)
- HER2: Negative (IHC 1+)
- Ki-67: 15%

## Imaging
- MRI (2026-07-29): Partial imaging response with residual 1.7 cm enhancement at the known left-breast malignancy.
- Axillary node: Interval normalization; previously metastatic left axillary node no longer enlarged; clipped node present on imaging.
- Right breast: No suspicious enhancement.
- Skin/chest wall: No thickening or invasion.
- Comparison: MRI 2026-04-23.

## Treatment History
- Neoadjuvant therapy: Dose-dense doxorubicin/cyclophosphamide (ddAC) followed by paclitaxel; final paclitaxel dose on 2026-07-20; completed without dose-limiting toxicity.
- Surgery: Left image-guided partial mastectomy with sentinel lymph-node biopsy and targeted excision of clipped axillary node performed on 2026-08-07.
  - Intraoperative: Localization marker/clip in specimen; three axillary nodes removed (including clipped node); margins addressed with additional margins.
  - Estimated blood loss: 20 mL.
- Postoperative plan: Systemic therapy and radiation therapy to be finalized after pathology review.

## Relevant Laboratory Findings
- Preoperative CBC/CMP (2026-08-05):
  - Hemoglobin: 12.1 g/dL
  - White blood cells: 5.8 x10^9/L
  - Absolute neutrophil count: 3.4 x10^9/L
  - Platelets: 231 x10^9/L
  - Creatinine: 0.79 mg/dL
  - AST: 22 U/L
  - ALT: 19 U/L
  - Total bilirubin: 0.5 mg/dL

## Clinical Timeline
- 2026-04 (month): Diagnosis of left breast invasive ductal carcinoma; AJCC 8th edition stage IIB (cT2 cN1 cM0); ER+/PR-/HER2-; plan for neoadjuvant therapy.
- 2026-04 to 2026-07 (range): Neoadjuvant ddAC followed by paclitaxel.
- 2026-07-20: Final paclitaxel dose administered; therapy completed without dose-limiting toxicity.
- 2026-07-29: Breast MRI shows partial response with 1.7 cm residual lesion; left axillary node normalized; clip present.
- 2026-08-03: Medical oncology note: current disease state shows partial radiographic response; plan for surgery; mild fatigue.
- 2026-08-07: Surgery performed: Left partial mastectomy with sentinel node biopsy and targeted excision of clipped axillary node.
- 2026-08-12: Final pathology report issued for partial mastectomy and sentinel node biopsy; residual treated carcinoma; margins negative; ypT1c ypN0(sn); ER 90%, PR <1%, HER2 1+, Ki-67 15%.

## Missing or Unclear Information
- Exact date of initial diagnosis in April 2026 (day not provided).
- Exact start date of neoadjuvant chemotherapy (not specified; only end date 2026-07-20).
- Exact margins distance beyond the closest invasive margin (distance beyond 6 mm not specified).
- Postoperative systemic therapy and radiation timing/details to be finalized after pathology review.

## Source Documents
- pathology: provided_document (synthesized final pathology: tumor size, grade, margins, ER/PR/HER2, Ki-67, node status) and associated notes.
- imaging: breast_mri_treatment_response_2026-07-29 (left-breast residual enhancement; axillary node normalization; clip present).
- clinical: Medical Oncology Follow-up / preoperative handoff (initial diagnosis, stage, biology, neoadjuvant therapy timeline, current disease state, planned surgery, postoperative plans).
- surgery: operative_report.pdf (date 2026-08-07; left partial mastectomy with sentinel node biopsy and clipped node excision; margins; EBL).
- laboratory: lab_results.pdf (preoperative CBC/CMP dated 2026-08-05).



---

### Step 12: final verification (Terminal Output)

# Clinical Case Brief

---

## One-line summary
Post-neoadjuvant therapy left breast invasive ductal carcinoma with partial radiographic response; pathology shows residual treated tumor with negative margins and ypT1c ypN0(sn) status; axillary node metastasis not identified.

## Current Clinical Status
- Diagnosis: Left breast invasive ductal carcinoma.
- Stage/status: Pathologic stage ypT1c ypN0(sn) after partial mastectomy with sentinel node biopsy; margins negative (closest invasive margin 6 mm); residual in situ DCIS present; treatment-related fibrosis in clipped node; ER 90% positive, PR <1% (negative), HER2 1+ (negative); Ki-67 15%.
- Performance status: Not explicitly stated; clinically well with mild fatigue post-neoadjuvant therapy.
- Current treatment: Undergoing planned postoperative management; specifics of systemic therapy and radiation to be finalized after pathology review.

## Diagnosis & Pathology
- Specimen: Partial mastectomy with sentinel lymph node biopsy; clipped axillary node included.
- Tumor size: 1.4 cm (greatest dimension) residual invasive tumor.
- Histology: Nottingham grade 2 of 3 invasive carcinoma; focal intermediate-grade DCIS.
- Margins: All submitted margins negative for invasive carcinoma and DCIS; closest invasive margin 6 mm.
- Lymph nodes: 3 nodes examined; 0 positive for carcinoma; treatment-related fibrosis in the clipped node.
- Lymphovascular invasion: Not identified.
- Biomarkers: ER positive (90% strong nuclear staining); PR negative (<1%); HER2 negative (IHC 1+); Ki-67 15%.
- Pathologic stage: ypT1c ypN0(sn).

## Biomarkers / Molecular Findings
- Estrogen receptor: Positive (90%)
- Progesterone receptor: Negative (<1%)
- HER2: Negative (IHC 1+)
- Ki-67: 15%

## Imaging
- MRI (2026-07-29): Partial imaging response with residual 1.7 cm enhancement at the known left-breast malignancy.
- Axillary node: Interval normalization; previously metastatic left axillary node no longer enlarged; clipped node present on imaging.
- Right breast: No suspicious enhancement.
- Skin/chest wall: No thickening or invasion.
- Comparison: MRI 2026-04-23.

## Treatment History
- Neoadjuvant therapy: Dose-dense doxorubicin/cyclophosphamide (ddAC) followed by paclitaxel; final paclitaxel dose on 2026-07-20; completed without dose-limiting toxicity.
- Surgery: Left image-guided partial mastectomy with sentinel node biopsy and targeted excision of clipped axillary node performed on 2026-08-07.
  - Intraoperative: Localization marker/clip in specimen; three axillary nodes removed (including clipped node); margins addressed with additional margins.
  - Estimated blood loss: 20 mL.
- Postoperative plan: Systemic therapy and radiation therapy to be finalized after pathology review.

## Relevant Laboratory Findings
- Preoperative CBC/CMP (2026-08-05):
  - Hemoglobin: 12.1 g/dL
  - White blood cells: 5.8 x10^9/L
  - Absolute neutrophil count: 3.4 x10^9/L
  - Platelets: 231 x10^9/L
  - Creatinine: 0.79 mg/dL
  - AST: 22 U/L
  - ALT: 19 U/L
  - Total bilirubin: 0.5 mg/dL

## Clinical Timeline
- 2026-04 (month): Diagnosis of left breast invasive ductal carcinoma; AJCC 8th edition stage IIB (cT2 cN1 cM0); ER+/PR-/HER2-; plan for neoadjuvant therapy.
- 2026-04 to 2026-07 (range): Neoadjuvant ddAC followed by paclitaxel.
- 2026-07-20: Final paclitaxel dose administered; therapy completed without dose-limiting toxicity.
- 2026-07-29: Breast MRI shows partial response with 1.7 cm residual lesion; left axillary node normalized; clip present.
- 2026-08-03: Medical oncology note: current disease state shows partial radiographic response; plan for surgery; mild fatigue.
- 2026-08-07: Surgery performed: Left partial mastectomy with sentinel node biopsy and targeted excision of clipped axillary node.
- 2026-08-12: Final pathology report issued for partial mastectomy and sentinel node biopsy; residual treated carcinoma; margins negative; ypT1c ypN0(sn); ER 90%, PR <1%, HER2 1+, Ki-67 15%.

## Missing or Unclear Information
- Exact date of initial diagnosis in April 2026 (day not provided).
- Exact start date of neoadjuvant chemotherapy (not specified; only end date 2026-07-20).
- Exact margins distance beyond the closest invasive margin (distance beyond 6 mm not specified).
- Postoperative systemic therapy and radiation timing/details to be finalized after pathology review.

## Source Documents
- pathology: provided_document (synthesized final pathology: tumor size, grade, margins, ER/PR/HER2, Ki-67, node status) and associated notes.
- imaging: breast_mri_treatment_response_2026-07-29 (left-breast residual enhancement; axillary node normalization; clip present).
- clinical: Medical Oncology Follow-up / preoperative handoff (initial diagnosis, stage, biology, neoadjuvant therapy timeline, current disease state, planned surgery, postoperative plans).
- surgery: operative_report.pdf (date 2026-08-07; left partial mastectomy with sentinel node biopsy and clipped node excision; margins; EBL).
- laboratory: lab_results.pdf (preoperative CBC/CMP dated 2026-08-05).

---

